Skinbiotherapeutics (LON:SBTX) Shares Down 4.8%

Shares of Skinbiotherapeutics PLC (LON:SBTX) traded down 4.8% on Thursday . The company traded as low as GBX 14.50 ($0.19) and last traded at GBX 15 ($0.20), 382,186 shares traded hands during trading. An increase of 46% from the average session volume of 261,826 shares. The stock had previously closed at GBX 15.75 ($0.21).

The firm has a market cap of $19.85 million and a PE ratio of -17.22. The business has a fifty day moving average price of GBX 15.17 and a two-hundred day moving average price of GBX 18.42.

Skinbiotherapeutics Company Profile (LON:SBTX)

SkinBioTherapeutics plc, a life science company, engages in the research and development of lysates derived from the human microbiome on skin. It is developing pre-clinical product application, SkinBiotix, a cosmetic cream for skin health, as well as for applications in infection control and eczema. The company was formerly known as Skinbiotix Ltd.

Featured Story: Which market index is the best?

Receive News & Ratings for Skinbiotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Skinbiotherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.